Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com.
Company Details
- Employees
- 864
- Address
- Vondellaan 47, Leiden,2332 Aa,netherlands
- Phone
- +31 (0)71 5247 400
- in****@****ing.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pharming.com
- Keywords
- precision medicine, protein replacement therapies, biologics, rare diseases, drug development, biotechnology.
- HQ
- Leiden
Pharming Group Questions
Pharming Group's helpline number is +31 (0)71 5247 400
Pharming Group's website is pharming.com
Pharming Group's LinkedIn profile is https://www.linkedin.com/company/pharming
Pharming Group has
864 employees.
View email and phone details for 864
employees at Pharming Group.
Pharming Group's industry is
Biotechnology Research
Pharming Group's top competitors are
Galapagos,
Argenx,
Johnson & Johnson,
Merus N.v.,
Batavia Biosciences,
Proqr Therapeutics,
Pharming Healthcare, Inc.,
Uniqure,
Genmab,
Abliva Ab.
Pharming Group's support email address is info@pharming.com
Pharming Group's categories are Biotechnology Research
